A New Year, but the Same Old Stock Market
The new year was to have brought a new beginning for China's stock market. Instead, investors who were set to welcome the return of IPO action after a suspension of 14 months were disappointed by news on January 10 that Jiangsu Aosaikang Pharmaceutical Co. Ltd. was putting its anticipated initial public offering on hold.
The abrupt postponement has sparked questions about the regulator's reform agenda. Clearly, at a time when it is trying to clarify its own role vis-à-vis the market, the regulator has yet to master the art of timing. Xiao Gang, chairman of the China Securities Regulatory Commission, said at a work conference this month that reform will see a complete overhaul of the regulator's scope of oversight of the capital market. Its recent actions must be seen in light of this pledge.
- Hospitals No Longer Take Organs from Executed Prisoners, Official Says
- Underground Disturbance
- Home Burial
- Closer Look: So Apple and Alipay Are Getting Married? Not So Fast
- Job Websites Adapt to Changing Industry by Targeting Individuals, Special Groups
- Graphic: Rising Tide of Investment
- Closer Look: CSRC Should Review Its Approvals-Based IPO System
- China's Growing Private Sector
- Advisory Body Votes to Raise Subway, Bus Fares in Capital
- Earning Trust of the People Requires Rule of Law
- Sign up to receive our free daily newsletter
- Rise and Fall of a Coal Boomtown in Shanxi Province
- Researchers Cast Doubt on State Council Goals to Cut Air Pollution
- Chinese Comfort Women: Testimonies from Imperial Japan's Sex Slaves
- Which Way for Smartphone Swipe and Pay?
- What is Authoritarianism?
- Zuckerberg Impresses Tsinghua Students with His Chinese, Even Talks Tech
- Alibaba Shopping Site Red-Faced after Number of Phone Orders Faked
- For China's Property Market, All Is Not Lost
- Cai Jinyong: A Chinese Voice at the Top of IFC
- Ministry Said to Propose Local Gov'ts Issuing Bonds to Cover Debts